PERICOLINI, Eva
 Distribuzione geografica
Continente #
NA - Nord America 15.138
AS - Asia 7.316
EU - Europa 6.745
SA - Sud America 1.029
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 196
OC - Oceania 56
Totale 30.756
Nazione #
US - Stati Uniti d'America 14.749
SG - Singapore 2.229
IT - Italia 1.897
GB - Regno Unito 1.830
CN - Cina 1.675
HK - Hong Kong 825
BR - Brasile 741
VN - Vietnam 711
DE - Germania 553
SE - Svezia 501
BD - Bangladesh 417
RU - Federazione Russa 283
FR - Francia 280
UA - Ucraina 260
FI - Finlandia 252
IN - India 237
KR - Corea 237
TR - Turchia 232
ID - Indonesia 203
CA - Canada 185
PL - Polonia 162
BG - Bulgaria 120
MX - Messico 112
AR - Argentina 92
IQ - Iraq 81
RO - Romania 81
NL - Olanda 75
JP - Giappone 73
BE - Belgio 65
ZA - Sudafrica 63
ES - Italia 50
MY - Malesia 49
EC - Ecuador 47
IE - Irlanda 46
HU - Ungheria 45
PK - Pakistan 45
AU - Australia 44
AE - Emirati Arabi Uniti 43
CL - Cile 43
LT - Lituania 42
AT - Austria 41
CO - Colombia 39
IR - Iran 39
PT - Portogallo 31
EG - Egitto 29
CH - Svizzera 26
MA - Marocco 25
PE - Perù 25
TH - Thailandia 25
UZ - Uzbekistan 25
PH - Filippine 23
NO - Norvegia 22
IL - Israele 20
DZ - Algeria 18
JM - Giamaica 18
CZ - Repubblica Ceca 17
VE - Venezuela 17
SA - Arabia Saudita 16
TW - Taiwan 16
PY - Paraguay 15
AZ - Azerbaigian 12
CR - Costa Rica 12
NP - Nepal 12
DO - Repubblica Dominicana 11
GR - Grecia 11
JO - Giordania 11
KE - Kenya 11
TN - Tunisia 11
NZ - Nuova Zelanda 10
BB - Barbados 9
DK - Danimarca 9
GT - Guatemala 9
KW - Kuwait 8
OM - Oman 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 6
ET - Etiopia 6
HN - Honduras 6
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
UG - Uganda 6
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AL - Albania 4
CG - Congo 4
CI - Costa d'Avorio 4
LK - Sri Lanka 4
MT - Malta 4
NG - Nigeria 4
SI - Slovenia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
Totale 30.428
Città #
Singapore 1.586
Santa Clara 1.567
Ashburn 1.422
Fairfield 1.343
Southend 1.065
Woodbridge 787
Hong Kong 783
San Jose 763
Council Bluffs 706
Chandler 631
Houston 577
Seattle 493
Wilmington 423
Jacksonville 389
Hefei 383
Cambridge 382
Dearborn 380
Beijing 377
London 319
Ann Arbor 311
Nyköping 262
Modena 258
Los Angeles 232
New York 230
Ho Chi Minh City 217
Seoul 201
Hanoi 159
Milan 157
The Dalles 156
Helsinki 147
Jakarta 138
Dallas 124
San Diego 122
Sofia 113
Buffalo 110
Princeton 103
Kraków 101
Bremen 99
Lauterbourg 99
Chicago 94
Bologna 93
Columbus 93
Eugene 91
Rome 85
Moscow 83
Redwood City 76
São Paulo 74
Orem 73
Izmir 64
Tokyo 62
Timisoara 57
Carpi 56
Chennai 56
Reggio Emilia 56
Shanghai 55
Exeter 54
Nuremberg 50
Boardman 45
Atlanta 43
Phoenix 43
Haiphong 42
Munich 42
Warsaw 42
Guangzhou 41
Toronto 41
Frankfurt am Main 40
Mexico City 39
Johannesburg 38
Nanjing 38
Parma 38
Da Nang 37
Dublin 37
Montreal 36
Brooklyn 33
Verona 33
Dong Ket 32
Brussels 31
Denver 31
San Francisco 31
Porto Alegre 30
Salt Lake City 29
Baghdad 28
Mumbai 28
Perugia 28
Amsterdam 25
Boston 25
Stockholm 25
Trieste 25
Florence 24
Poplar 24
Dongguan 23
Falls Church 23
Norwalk 23
Rio de Janeiro 23
Kent 22
Naples 22
Lappeenranta 21
Basingstoke 20
Istanbul 20
Kuala Lumpur 20
Totale 20.328
Nome #
Zinc treatment prevents neutrophil recruitment and inflammation by blocking Candida albicans Pra1 during vulvovaginal candidiasis. 930
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 489
Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response 465
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 444
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 398
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 396
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 387
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 376
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 369
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 364
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 353
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 348
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 348
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 344
Effects of different mouthwashes on biofilm formation by oral streptococci 339
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 336
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 324
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 323
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 321
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 320
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 316
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 313
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 312
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 312
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 311
A Purified Capsular Polysaccharide Markedly Inhibits Inflammatory Response during Endotoxic Shock 305
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 301
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity 299
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 299
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice 293
Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis 281
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production 280
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 278
Hyphal morphology, molecular genetics and phylogenetic relationships among commensal and pathogenic vulvovaginal isolates of Candida albicans 278
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis 273
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 271
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 269
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients 267
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 266
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 265
A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice 263
Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. 255
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage 254
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 249
Inflammatory response during human vaginal infection with Candida albicans 248
Peptides of the constant region of antibodies display fungicidal activity 248
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. 245
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 245
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans 244
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 243
Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression 240
Saccharomyces cerevisiae as a new therapeutic agent against oropharyngeal candidiasis 239
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 236
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis 233
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 231
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 230
The Candida albicans Pra1 zincophore promotes neutrophils recruitment and inflammation during vulvovaginal candidiasis 230
Experimental models of vaginal candidiasis and inflammation 228
Comparative analysis of commensal and pathogenic vulvovaginal clinical isolates of Candida albicans: hyphal morphology, molecular genetics and phylogenetic relationships 228
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 226
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 225
A role for secretory aspartyl proteinase of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 224
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 222
GILZ restrains neutrophil activation by inhibiting the MAPK pathway 220
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 215
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges 214
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis 214
Involvement of glycoreceptors in galactoxylomannan-induced T cell death 214
Chronic vaginal candidiasis is achievable in outbred CD-1 mice 211
Gray phenotype: enhanced fitness strategy for Candida dubliniensis 210
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response. 208
Elucidating the immunological function of the Cryptococcus neoformans capsule 207
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 207
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity 207
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 206
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response 206
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor 206
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 205
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 203
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts 202
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome 201
A new strategy to prevent biofilm and clot formation in medical devices: the use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings 199
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 199
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 197
In vivo induction of neutrophils chemotaxis by secretory aspartyl proteinases of Candida albicans 197
Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars 195
A microbial polysaccharide reduces the severity of rheumatoid arthtritis via inhibition of Th17 differentiation 194
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages 194
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection 193
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 193
Any antibody fragment might exert antifungal activity 189
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 188
Immunomodulatory properties of heat-inactivated biomasses by selected bacterial and fungal species included in the Qualified Presumption of Safety list of the European Food Safety Authority 187
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages 187
Therapeutic activity of Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 186
The pathogenic and colonization potential of Candida africana 183
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice 181
In vivo colonization and pathogenic potential of C. africana 179
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 178
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 177
Totale 26.601
Categoria #
all - tutte 108.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.596 0 0 273 91 46 98 103 92 197 166 330 200
2022/20232.193 181 161 202 203 293 272 67 212 298 62 122 120
2023/20241.961 80 124 147 123 244 251 142 252 73 163 149 213
2024/20255.335 200 120 127 394 1.165 850 266 365 519 383 430 516
2025/20269.851 542 380 572 1.171 1.275 706 1.168 559 935 1.071 879 593
2026/20271.533 674 809 50 0 0 0 0 0 0 0 0 0
Totale 30.756